School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; State Key Lab of New Ceramics and Fine Processing, School of Materials Science and Engineering, Tsinghua University, Beijing 100084, China; Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin 301617, China.
School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin 301617, China.
Phytomedicine. 2024 Jan;123:155241. doi: 10.1016/j.phymed.2023.155241. Epub 2023 Nov 23.
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases encountered in clinical practice. Curcumin can alleviate insulin resistance, inhibit oxidative stress response, reduce inflammation, reduce liver fat deposition, and effectively improve NAFLD through various modalities, inhibiting the progression into cirrhosis and fibrosis.
To explore the current status, hot spots, and developing trends of curcumin in NAFLD treatment through quantitative scientific analysis to serve as a reference for subsequent studies.
A comprehensive analysis of the mechanism of action of curcumin in the treatment of NAFLD and methods to increase curcumin bioavailability using bibliometric analysis and literature review.
This study used VOSviewer software to analyze the literature related to curcumin treatment of NAFLD in the Web of Science (WOS) core set database. A comprehensive and in-depth review was conducted based on the results of scientific econometric research and literature review.
The review observed that curcumin can activate various signaling pathways such as AMPK and NF-κB to inhibit oxidative stress and apoptosis, thereby reflecting its pharmacological effects: lowering lipid, anti-inflammatory, reducing insulin resistance, and anti-fibrosis. These mechanisms improve or even reverse the complex pathological features of lipid metabolism disorders associated with NAFLD. Curcumin also can potentially serve as a primary regulatory target for treating hepatic steatosis using gut microbiota. However, these pharmacological effects of curcumin were limited owing to its low bioavailability.
This review discusses NAFLD treatment with curcumin, analyzes the reasons for its low bioavailability, and introduces models for studying and methods for improving curcumin bioavailability. As research on NAFLD grows, future research should capture the trend of basic research, pay attention to clinical research, and continuously explore the therapeutic potential of curcumin.
非酒精性脂肪性肝病(NAFLD)是临床实践中最常见的慢性肝病之一。姜黄素可以通过多种方式缓解胰岛素抵抗、抑制氧化应激反应、减轻炎症、减少肝脂肪沉积,有效改善 NAFLD,抑制其向肝硬化和纤维化进展。
通过定量科学分析,探讨姜黄素治疗 NAFLD 的现状、热点和发展趋势,为后续研究提供参考。
采用文献计量学分析和文献综述对姜黄素治疗 NAFLD 的作用机制和提高姜黄素生物利用度的方法进行综合分析。
本研究使用 VOSviewer 软件对 Web of Science(WOS)核心集数据库中与姜黄素治疗 NAFLD 相关的文献进行分析。在科学计量学研究和文献综述结果的基础上,进行了全面深入的综述。
综述观察到姜黄素可以激活 AMPK 和 NF-κB 等多种信号通路,抑制氧化应激和细胞凋亡,从而反映其药理作用:降低血脂、抗炎、降低胰岛素抵抗、抗纤维化。这些机制改善甚至逆转了与 NAFLD 相关的脂质代谢紊乱的复杂病理特征。姜黄素还可能作为治疗肝脂肪变性的主要调节靶点,通过肠道微生物群。然而,由于其生物利用度低,姜黄素的这些药理作用受到限制。
本综述讨论了用姜黄素治疗 NAFLD,分析了其生物利用度低的原因,并介绍了研究和提高姜黄素生物利用度的方法。随着对 NAFLD 研究的增加,未来的研究应捕捉基础研究的趋势,关注临床研究,并不断探索姜黄素的治疗潜力。